[Fiberoptic bronchoscopy in a respiratory intensive care unit]

Med Intensiva. 2012 Aug-Sep;36(6):389-95. doi: 10.1016/j.medin.2011.11.004. Epub 2011 Dec 22.
[Article in Spanish]

Abstract

Objective: To describe the indications, diagnostic performance and safety of fiberoptic bronchoscopy (FOB) performed in a respiratory intensive care unit (RICU).

Design: A prospective, observational study was carried out.

Setting: A 6-bed RICU in a tertiary university hospital.

Patients: Patients admitted to RICU who required FOB.

Interventions: None.

Main measurements: FOB indications and complications, endoscopic procedures, time required to perform FOB.

Results: Sixty-nine out (23%) of the 297 patients admitted to the RICU underwent a total of 107 FOB. Sixty-eight percent of FOB were performed in patients on mechanical ventilation. FOB was performed for diagnostic and therapeutic purposes in 88 (82%) and 19 cases (18%), respectively. The study of pulmonary infiltrates was the main indication for diagnostic FOB (44 cases; 50%), particularly in immunocompromised patients (24 cases; 27%). In immunocompromised patients the diagnostic performance of FOB was significantly higher than in immunocompetent subjects (48% vs 30%; p<0.01). No major complications were recorded. Only a significant drop in PaO(2)/FiO(2) ratio was observed (182 ± 74 vs 163 ± 79; p<0.005) in patients undergoing bronchoalveolar lavage. Overall mortality in patients in the RICU was 14%. In patients requiring a single FOB procedure, mortality was 25%, versus 45% among those requiring more than one FOB procedure.

Conclusions: These results show that FOB is used commonly in the RICU. It is a safe and fast procedure that contributes significantly to clinical management. Patients requiring additional FOB during admission to the RICU show high mortality.

MeSH terms

  • Aged
  • Biopsy / methods
  • Bronchoalveolar Lavage Fluid
  • Bronchoscopes
  • Bronchoscopy* / adverse effects
  • Bronchoscopy* / statistics & numerical data
  • Female
  • Fiber Optic Technology / instrumentation*
  • Hospital Mortality
  • Humans
  • Immunocompromised Host
  • Male
  • Middle Aged
  • Prospective Studies
  • Reproducibility of Results
  • Respiration, Artificial
  • Respiratory Care Units / methods*
  • Respiratory Tract Diseases / diagnosis*
  • Respiratory Tract Diseases / surgery*
  • Sensitivity and Specificity
  • Tertiary Care Centers